Astrazeneca Pharma India Ltd

ASTRAZEN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,541 cr, stock is ranked 426
Low RiskStock is 1.89x as volatile as Nifty
2,993.1023.65 (-0.78%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,541 cr, stock is ranked 426
Low RiskStock is 1.89x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
80.83
PB RatioPB Ratio
16.53
Dividend YieldDiv. Yield
0.07%
Sector PESector PE
37.99
Sector PBSector PB
5.06
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

AstraZeneca Pharma India Limited is a biopharmaceutical company engaged in the discovery, development and commercialization of medicines for core areas of healthcare.

Brands

Astrazeneca Pharma

Pharmaceutical company

Brands

Astrazeneca Pharma

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021583.25744.58844.80826.4025.9154.4572.2193.30
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnJan 20, 2022

AstraZeneca Pharma India Limited has informed the Exchange regarding 'Certificate dated January 3, 2022 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. '. | Download

AstraZeneca Pharma India Limited has informed the Exchange regarding 'Certificate dated January 3, 2022 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. '. | Download

Appointment 
Announced OnDec 30, 2021

AstraZeneca Pharma India Limited has informed the Exchange regarding Appointment of Ms Shilpa Shridhar Divekar as Non- Executive Independent Director of the company w.e.f. December 29, 2021. | Download

AstraZeneca Pharma India Limited has informed the Exchange regarding Appointment of Ms Shilpa Shridhar Divekar as Non- Executive Independent Director of the company w.e.f. December 29, 2021. | Download

Cash Dividend 
Ex. DateAug 18, 2021

Interim • Div/Share: ₹ 2

See all events